This is a study were subjects were randomized to use 3 different concentration of e-nicotine liquid. The subject used the product at home for 2 weeks. This 2-week period allowed subjects to become familiar with the e-cigarette. After two weeks, the subjects were confined to the clinical for one day. They were required to not use any e-cigarettes for 12 hours prior to the visit. Subjects had to have CO level below a pre-specified level, to attend the visit. If the level, was too high, the visit was re-scheduled. Subjects were instructed to take 10 puffs on the e-cigarette in the morning and afternoon. Puff topography was measured in the morning and afternoon using the same device for all subjects. Subjects were not allowed to use any tobacco products between the morning and afternoon sessions.
A Study Reference domain, DI, was used to identify the device used to measure puff topography. The provide a consistent sponsor-defined variable (SPDEVID) for linking data. Device identifiers exist independently from subjects; therefore, the DI domain does not contain USUBJID. Only one device was used for all subjects in the study.
di.xpt
di.xpt
Row
STUDYID
DOMAIN
SPDEVID
DISEQ
DIPARMCD
DIPARM
DIVAL
1
TOPT001
DI
PUFANYXYZ
1
DEVTYPE
Device Type
PUFF TOPOGRAPHER
2
TOPT001
DI
PUFANYXYZ
2
MODEL
Model
PUFFALYZER 900
3
TOPT001
DI
PUFANYXYZ
3
MANUF
Manufacturer
ACME
Dataset Debug Messages
There are two leading, trailing, or non-breaking spaces in the dataset.
The sponsor submitted the EX domain to represent the usage of the e-cigarettes. For each subject, the usage for the two weeks are represented, and then the specified usage during the in-clinic visit are shown. The sponsor elected not to represent each puff in this EX dataset. Each Puff could have been recorded.
ex.xpt
ex.xpt
Row
STUDYID
DOMAIN
USUBJID
EXSEQ
SPTOBID
EXLNKID
EXTRT
EXDOSE
EXDOSU
EXROUTE
EXPSTRG
EXPSTRGU
EXSTDTC
EXENDTC
1
TOPT001
EX
3001
1
EC-333
e-nicotine liquid
AD LIBITUM
INHALED
8
mg/mL
2020-06-26
2020-07-14
2
TENDS01
EX
3001
2
EC-333
1
e-nicotine liquid
10
PUFFS
INHALED
8
mg/mL
2020-07-15T9:00
2020-07-15TT9:45
3
TENDS01
EX
3001
3
EC-333
2
e-nicotine liquid
10
PUFFS
INHALED
8
mg/mL
2020-07-15T3:00
2020-07-15TT3:45
4
TENDS01
EX
4001
1
EC-333
e-nicotine liquid
AD LIBITUM
INHALED
16
mg/mL
2020-09-06
2020-09-22
5
TENDS01
EX
4001
2
EC-333
1
e-nicotine liquid
10
PUFFS
INHALED
16
mg/mL
2020-09-22T9:00
2020-09-22T9:30
6
TENDS01
EX
4001
3
EC-333
2
e-nicotine liquid
10
PUFFS
INHALED
16
mg/mL
2020-09-22T3:00
2020-09-22T3:30
$warningHtml
The FAEX domain was used to represent the puff topography associated with the in-clinic visit. A puff -by puff analysis was performed. FATPT was used to represent the time point, in this case, AM and PM. Typically, the sponsor derives summary results using the individual source data records, these summary results are represented in ADaM. However, if summary results are collected on a CRF or provided by an external vendor. these derived results can be represented in FAEX using the variable FACOLSRT,
Rows 1, 6:
Shows the Number of Puff taken in the time interval specified in FADTC and FAENDTC. This was pre-specified in the design, but the sponsor reported the actual number of puffs taken.
Rows 2-5
Show the various measurements recorded for subject 3001 for Puff 1 during the morning administration of the tobacco product. FADTC and FAENDTC provides the timing of each puff. The individual puff data for the afternoon are not shown.
Rows 6-10
Show the various measurements recorded for subject 3001 for Puff 10 during the afternoon administration of the tobacco product. FADTC and FAENDTC provides the timing of each puff. The individual puff data for the morning session are not shown. Note the data for PUFFS 2-9 are not shown to save space.
Rows 12-15
Shows the various measurements recorded for subject 4001. Only a few rows are shown to save space.
Row Captions Debug Messages
Remember to keep number agreement between labels and captions.
Please construct row caption labels as instructed in <ac:link><ri:page ri:content-title="Constructing labels for row captions" ri:space-key="TTD"/></ac:link>.
fa.xpt
faex.xpt
Row
STUDYID
DOMAIN
USUBJID
SPDEVID
FASEQ
FALNKID
FASPID
FATESTCD
FATEST
FAOBJ
FACAT
FAORRES
FAORRESU
FASTRESC
FASTRESU
FALOBXFL
VISITNUM
FADTC
FAENDTC
FATPT
1
TGI400
FA
3001
PUFANYXYZ
1
1
PUFF TOT
TOTAL NUMBER OF PUFFS
e-nicotine liquid
PUFF TOPOGRAPHY
10
PUFFS
10
PUFFS
2
2020-07-15T9:00
2020-07-15TT9:45
AM
2
TGI400
FA
3001
PUFANYXYZ
2
1
PUFF 1
PUFFVOL
PUFF VOLUME
e-nicotine liquid
PUFF TOPOGRAPHY
66.7
ml/sec
98
ml/sec
2
2020-07-15T9:00
AM
3
TGI400
FA
3001
PUFANYXYZ
3
1
PUFF 1
AVGFLOW
Average Flow rate
e-nicotine liquid
PUFF TOPOGRAPHY
AM
4
TGI400
FA
3001
PUFANYXYZ
4
1
PUFF 1
PKFLOW
Peak Flow Rate
e-nicotine liquid
PUFF TOPOGRAPHY
AM
5
TGI400
FA
3001
PUFANYXYZ
5
1
PUFF 1
PUFFDUR
Puff Duration
e-nicotine liquid
PUFF TOPOGRAPHY
6
TGI400
FA
3001
PUFANYXYZ
6
2
PUFF TOT
TOTAL NUMBER OF PUFFS
e-nicotine liquid
PUFF TOPOGRAPHY
10
PUFFS
10
PUFFS
2
7
TGI400
FA
3001
PUFANYXYZ
7
2
PUFF 10
INTPUFIN
Puff Interval
e-nicotine liqui
PUFF TOPOGRAPHY
AM
8
TGI400
FA
3001
PUFANYXYZ
8
2
PUFF 10
PUFFVOL
PUFF VOLUME
e-nicotine liquid
PUFF TOPOGRAPHY
43
ml/sec
43
ml/sec
2
2020-07-15T9:11
AM
9
TGI400
FA
3001
PUFANYXYZ
9
2
PUFF 10
AVGFLOW
Average Flow rate
e-nicotine liquid
PUFF TOPOGRAPHY
10
TGI400
FA
3001
PUFANYXYZ
10
2
PUFF 10
PKFLOW
Peak Flow Rate
e-nicotine liquid
PUFF TOPOGRAPHY
12
TGI400
FA
4001
PUFANYXYZ
1
1
PUFF TOT
TOTAL NUMBER OF PUFFS
e-nicotine liquid
PUFF TOPOGRAPHY
10
PUFFS
10
PUFFS
2
2020-07-15T9:00
2020-07-15TT9:45
AM
13
TGI400
FA
4001
PUFANYXYZ
2
1
PUFF 1
PUFFVOL
PUFF VOLUME
e-nicotine liquid
PUFF TOPOGRAPHY
2
sec
2
sec
2
2020-07-22
AM
14
TGI400
FA
4001
PUFANYXYZ
3
1
PUFF 1
AVGFLOW
Average Flow rate
e-nicotine liquid
PUFF TOPOGRAPHY
1.8
sec
1.8
sec
2
2020-07-22
AM
15
TGI400
FA
4001
PUFANYXYZ
4
1
PUFF 1
PKFLOW
Peak Flow Rate
e-nicotine liquid
PUFF TOPOGRAPHY
1.8
sec
1.8
sec
2
2020-09-22T9:13
2020-09-22T9:30
AM
Dataset Debug Messages
There are eight leading, trailing, or non-breaking spaces in the dataset.